“SARS COV-2/COVID-19 Pandemic”. First is do no harm (Primum non nocere), the evolution of therapy and treatment COVID-19, a literature review

The presence of COVID-19 was first reported in late 2019 in Wuhan, China, and since then the infection has spread widely in China and around the world. The first cases of COVID-19 were linked to a live animal market in Wuhan, China, suggesting that the virus was initially transmitted from animals to humans. The absence of an effective treatment against severe respiratory syndrome secondary to coronavirus infection has led clinicians to utilized drugs, that are to be effective for the other medical conditions, and that are produced side effects or adverse events. We review the literature on SARS-CoV-2, of the diverse treatment of COVID-19 and describe, the side effects of the drugs, might to be inefficient , and the risk-benefit. How Critical Care Point view.